Cash And Equivalent Zmiana Data
AbbVie USD 13.29B 4.53B 2023-09
Abbott USD 7.84B 1.33B 2023-06
ALKERMES USD 647.71M 18.08M 2023-09
Amgen USD 10.94B 23.8B 2023-12
AstraZeneca USD 4.87B 793M 2023-09
Biogen USD 1.05B 1.24B 2023-12
BioMarin Pharmaceutical USD 755.13M 30.29M 2023-12
Bristol-Myers Squibb USD 11.46B 3.95B 2023-12
Eisai JPY 281.45B 12.15B 2023-09
Eli Lilly USD 2.38B 313.7M 2023-09
Gilead Sciences USD 8.43B 2.72B 2023-12
GlaxoSmithKline GBP 3.18B 37M 2023-09
Infinity Pharmaceuticals USD 17.75M 7.99M 2023-06
J&J USD 3.5B 497M 2023-09
Merck USD 8.6B 2.94B 2023-09
Neurocrine Biosciences USD 293.7M 133.5M 2023-09
Pacira USD 153.3M 54.18M 2023-12
Perrigo USD 598.3M 43.1M 2023-09
Pfizer USD 3.15B 516M 2023-09
Regeneron Pharmaceuticals USD 16.24B 14.09B 2023-12
Revance Therapeutics USD 179.32M 38.08M 2023-09
Roche Holding CHF 3.72B 1.27B 2023-06
UCB EUR 457M 442M 2023-06
Ultragenyx Pharmaceutical USD 777.11M 704.54M 2023-12
United Therapeutics USD 1.21B 100M 2023-12
Vertex Pharmaceuticals USD 11.11B 959.1M 2023-09
Zoetis USD 2.04B 288M 2023-12



AbbVie Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2024.